BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37676891)

  • 1. The Gull Alpha Power Lomax distributions: Properties, simulation, and applications to modeling COVID-19 mortality rates.
    Tolba AH; Muse AH; Fayomi A; Baaqeel HM; Almetwally EM
    PLoS One; 2023; 18(9):e0283308. PubMed ID: 37676891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Transmuted Generalized Lomax Distribution: Properties and Applications to COVID-19 Data.
    Abu El Azm WS; Almetwally EM; Naji Al-Aziz S; El-Bagoury AAH; Alharbi R; Abo-Kasem OE
    Comput Intell Neurosci; 2021; 2021():5918511. PubMed ID: 34630548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Gull Alpha Power Weibull distribution with applications to real and simulated data.
    Ijaz M; Asim SM; Alamgir ; Farooq M; Khan SA; Manzoor S
    PLoS One; 2020; 15(6):e0233080. PubMed ID: 32530965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivariate power Lomax distribution with medical applications.
    Qura ME; Fayomi A; Kilai M; Almetwally EM
    PLoS One; 2023; 18(3):e0282581. PubMed ID: 36888601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lomax exponential distribution with an application to real-life data.
    Ijaz M; Asim SM; Alamgir
    PLoS One; 2019; 14(12):e0225827. PubMed ID: 31826022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new generalization of Gull Alpha Power Family of distributions with application to modeling COVID-19 mortality rates.
    Kilai M; Waititu GA; Kibira WA; Alshanbari HM; El-Morshedy M
    Results Phys; 2022 May; 36():105339. PubMed ID: 35340982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian and Classical Inference for the Generalized Log-Logistic Distribution with Applications to Survival Data.
    Muse AH; Mwalili S; Ngesa O; Almalki SJ; Abd-Elmougod GA
    Comput Intell Neurosci; 2021; 2021():5820435. PubMed ID: 34671390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian and non-bayesian inference for logistic-exponential distribution using improved adaptive type-II progressively censored data.
    Dutta S; Alqifari HN; Almohaimeed A
    PLoS One; 2024; 19(5):e0298638. PubMed ID: 38753595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The power Lomax distribution with an application to bladder cancer data.
    Rady EA; Hassanein WA; Elhaddad TA
    Springerplus; 2016; 5(1):1838. PubMed ID: 27818876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weighted Lomax distribution.
    Kilany NM
    Springerplus; 2016; 5(1):1862. PubMed ID: 27822438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New generalized-X family: Modeling the reliability engineering applications.
    Wang W; Ahmad Z; Kharazmi O; Ampadu CB; Hafez EH; Mohie El-Din MM
    PLoS One; 2021; 16(3):e0248312. PubMed ID: 33788850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new versatile modification of the Rayleigh distribution for modeling COVID-19 mortality rates.
    Kilai M; Waititu GA; Kibira WA; El-Raouf MMA; Abushal TA
    Results Phys; 2022 Apr; 35():105260. PubMed ID: 35223386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classical and Bayesian inference for the new four-parameter Lomax distribution with applications.
    Abdullah M; Ahsan-Ul-Haq M; Alomair AM; Alomair MA
    Heliyon; 2024 Feb; 10(4):e25842. PubMed ID: 38384583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of COVID-19 vaccination rate using odd Lomax inverted Nadarajah-Haghighi distribution.
    Almongy HM; Almetwally EM; Haj Ahmad H; H Al-Nefaie A
    PLoS One; 2022; 17(10):e0276181. PubMed ID: 36269740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data analysis for COVID-19 deaths using a novel statistical model: Simulation and fuzzy application.
    El-Sherpieny EA; Almetwally EM; Muse AH; Hussam E
    PLoS One; 2023; 18(4):e0283618. PubMed ID: 37036849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-Power Exponentiated Inverse Rayleigh distribution and its applications to real and simulated data.
    Ali M; Khalil A; Ijaz M; Saeed N
    PLoS One; 2021; 16(1):e0245253. PubMed ID: 33444340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exponentiated Odd Lomax Exponential distribution with application to COVID-19 death cases of Nepal.
    Dhungana GP; Kumar V
    PLoS One; 2022; 17(6):e0269450. PubMed ID: 35657989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inference and quantile regression for the unit-exponentiated Lomax distribution.
    Fayomi A; Hassan AS; Almetwally EM
    PLoS One; 2023; 18(7):e0288635. PubMed ID: 37463159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the Daily Recovery Cases in Egypt for COVID-19 Using Power Odd Generalized Exponential Lomax Distribution.
    Mohamed H; Mousa SA; Abo-Hussien AE; Ismail MM
    Ann Data Sci; 2022; 9(1):71-99. PubMed ID: 38624809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimations of Generalized Exponential Distribution Parameters Based on Type I Generalized Progressive Hybrid Censored Data.
    Nagy M; Alrasheedi AF
    Comput Math Methods Med; 2022; 2022():8058473. PubMed ID: 35392586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.